A local pharmaceutical company has closed Central Florida’s second-biggest fundraising round of 2019.
Celebration-based KemPharm Inc. (Nasdaq: KMPH) closed a $71 million round on Dec. 23, according to a U.S. Securities and Exchange Commission filing. The capital was exchanged for senior convertible notes, which can be converted into equity in the company at a later date. New York-based investment bank Cowen & Co. LLC (Nasdaq: COWN) was the recipient of the notes, according to the filing. KemPharm couldn’t be reached for comment. Read more here.